Percentage of patients who report having experienced the paclitaxel-induced pain syndrome (PIAPS) for one week after paclitaxel after enrollment to the current trial, assessed by the Modified Brief Pain Inventory Scale (BPI) Up to 28 days [clinicaltrials_resource:e9874c9f264eca5aa614a7dfbd187500]

The per arm percentage of patients who report having experienced the PIAPS for one week after paclitaxel after enrollment to the current trial will be assessed based on the response to the question "Please rate your pain by circling the one number that best describes your pain at its worst in the last 24 hours". The area under the curves based on whether patients were assigned to the intervention arm versus placebo arm will be compared using two-sample t-tests.

Percentage of patients who report having experienced the paclitaxel-induced pain syndrome (PIAPS) for one week after paclitaxel after enrollment to the current trial, assessed by the Modified Brief Pain Inventory Scale (BPI) Up to 28 days [clinicaltrials_resource:e9874c9f264eca5aa614a7dfbd187500]

The per arm percentage of patients who report having experienced the PIAPS for one week after paclitaxel after enrollment to the current trial will be assessed based on the response to the question "Please rate your pain by circling the one number that best describes your pain at its worst in the last 24 hours". The area under the curves based on whether patients were assigned to the intervention arm versus placebo arm will be compared using two-sample t-tests.